What Was BES 2019?
BES 2019 refers to the Basel European Study, a population-based investigation centered on subclinical atherosclerosis and cardiovascular health. The study recruited participants from the Basel region of Switzerland, aiming to quantify the burden of early vascular changes in adults who had not yet developed clinical symptoms of heart disease. Researchers combined imaging data with detailed risk factor profiles to build a clearer picture of how atherosclerosis progresses silently over time.
More from this site
Keep reading the latest coverage
Study Design and Population
The cohort included a broad cross-section of the adult population, with enrollment based on random sampling from municipal registries. Participants underwent coronary artery calcium scoring and carotid intima-media thickness measurements, alongside standard blood draws for lipid panels and inflammatory markers. The design was cross-sectional in its core analysis, though longitudinal follow-up allowed the team to track incident cardiovascular events over several years. Exclusion criteria focused on individuals with prior myocardial infarction, stroke, or known coronary revascularization, isolating the study to primary prevention.
Key Findings on Subclinical Atherosclerosis
The central results highlighted the prevalence of coronary calcification and carotid plaque in asymptomatic adults. A substantial proportion of participants showed measurable calcium scores, even in younger age groups, challenging the assumption that vascular disease is exclusively an issue of older age. The data also demonstrated strong associations between calcification burden and traditional risk factors such as hypertension, dyslipidemia, and diabetes. Notably, the study provided age- and sex-specific reference values for calcium scores, which clinicians can use to contextualize individual patient results.
Risk Factor Clusters
BES 2019 identified clusters of risk factors that amplified subclinical disease burden beyond what any single factor would predict. The combination of elevated LDL cholesterol, low HDL cholesterol, and smoking produced a marked stepwise increase in calcium scores. Physical inactivity and central adiposity compounded these effects, reinforcing the importance of metabolic health as a unified target rather than a collection of isolated numbers.
Clinical and Public Health Implications
For practicing clinicians, the study offered evidence that imaging-based risk stratification captures a meaningful gradient of future event risk in apparently healthy populations. The findings support integrating coronary calcium scoring into shared decision-making conversations, particularly for patients whose traditional risk scores fall into intermediate categories. Public health planners in the Basel region used the data to calibrate prevention campaigns, targeting modifiable risk factors earlier in the life course.
Comparing BES 2019 With Other Cohorts
The BES 2019 results align with findings from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study, which also documented high rates of subclinical disease in asymptomatic populations. However, BES 2019 is distinctive for its narrow geographic base, which limits generalizability to more diverse ethnic populations while strengthening internal validity through uniform healthcare access and measurement protocols.
| Attribute | Detail | Context |
|---|---|---|
| Study Name | Basel European Study (BES 2019) | Population-based cohort from Basel, Switzerland |
| Primary Outcome | Subclinical atherosclerosis measured by coronary calcium scoring | Focus on asymptomatic individuals |
| Key Imaging | Coronary CT calcium, carotid intima-media thickness | Standardized acquisition protocols |
| Risk Factors Analyzed | Lipids, blood pressure, diabetes, smoking, adiposity | Traditional and metabolic cluster analysis |
| Population | Adults without prior cardiovascular events | Primary prevention focus |
| Reference Values | Age- and sex-specific calcium score percentiles | For clinical interpretation of scores |
Limitations to Keep in Mind
The geographic homogeneity of the Basel cohort means that findings may not translate directly to populations with different genetic backgrounds, dietary patterns, or healthcare systems. The cross-sectional nature of the core analysis limits causal inference about risk factor trajectories, and the reliance on calcium scoring alone does not capture non-calcified plaque, which can be clinically significant. Researchers have acknowledged these constraints and called for complementary studies in more diverse settings.
Bottom Line
BES 2019 reinforced the value of early vascular imaging in uncovering hidden atherosclerosis and provided actionable reference data for clinicians. By linking subclinical changes to conventional risk factors and incident events, the study supports a more personalized approach to primary prevention, where imaging and risk factor management work together rather than in isolation.